| __timestamp | Agios Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 24518692 |
| Thursday, January 1, 2015 | 35992000 | 19886580 |
| Friday, January 1, 2016 | 50714000 | 12631689 |
| Sunday, January 1, 2017 | 71124000 | 21977998 |
| Monday, January 1, 2018 | 114145000 | 20759000 |
| Tuesday, January 1, 2019 | 132034000 | 20838000 |
| Wednesday, January 1, 2020 | 149070000 | 121812000 |
| Friday, January 1, 2021 | 121445000 | 152137000 |
| Saturday, January 1, 2022 | 121673000 | 83231000 |
| Sunday, January 1, 2023 | 119903000 | 122706000 |
| Monday, January 1, 2024 | 156784000 |
Unleashing insights
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, TG Therapeutics, Inc. and Agios Pharmaceuticals, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Agios Pharmaceuticals saw a steady increase in SG&A expenses, peaking in 2020 with a 680% rise from 2014. Meanwhile, TG Therapeutics experienced a more volatile journey, with a significant spike in 2021, marking a 520% increase from its 2014 expenses. Despite these fluctuations, both companies have shown resilience, with TG Therapeutics slightly edging out Agios in 2023 by maintaining a more consistent expense trend. This analysis highlights the strategic financial maneuvers these companies employ to stay competitive in the ever-evolving biotech landscape.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Agios Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.